{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:07:29Z","timestamp":1791385649167,"version":"4.3.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12328-023-01839-1","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T19:01:41Z","timestamp":1691002901000},"page":"864-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Delayed brain metastasis in recurrent hepatocellular carcinoma following liver transplantation: a case report highlighting the predictive value of microvascular invasion"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-8920","authenticated-orcid":false,"given":"Bhrugun","family":"Anisetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tucker","family":"Coston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Babiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"issue":"11","key":"1839_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"1839_CR2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/lt.20128","volume":"10","author":"S Roayaie","year":"2004","unstructured":"Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl. 2004;10(4):534\u201340.","journal-title":"Liver Transpl"},{"issue":"9","key":"1839_CR3","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.transproceed.2006.08.095","volume":"38","author":"IR Schreibman","year":"2006","unstructured":"Schreibman IR, Bejarano P, Martinez EJ, et al. Very late recurrence of hepatocellular carcinoma after liver transplantation: case report and literature review. Transplant Proc. 2006;38(9):3140\u20133.","journal-title":"Transplant Proc"},{"key":"1839_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.733343","volume":"8","author":"W Yanhan","year":"2021","unstructured":"Yanhan W, Lianfang L, Hao L, et al. Effect of microvascular invasion on the prognosis in hepatocellular carcinoma and analysis of related risk factors: a two-center study. Front Surg. 2021;8: 733343.","journal-title":"Front Surg"},{"issue":"4","key":"1839_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000481315","volume":"6","author":"CE Costentin","year":"2017","unstructured":"Costentin CE, Ferrone CR, Arellano RS, et al. Hepatocellular carcinoma with macrovascular invasion: defining the optimal treatment strategy. Liver Cancer. 2017;6(4):360\u201374.","journal-title":"Liver Cancer"},{"issue":"3","key":"1839_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4254\/wjh.v11.i3.261","volume":"11","author":"NA Filgueira","year":"2019","unstructured":"Filgueira NA. Hepatocellular carcinoma recurrence after liver transplantation: risk factors, screening and clinical presentation. World J Hepatol. 2019;11(3):261\u201372.","journal-title":"World J Hepatol"},{"issue":"1","key":"1839_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35\u201343.","journal-title":"Lancet Oncol"},{"key":"1839_CR8","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.934924","volume":"27","author":"WA Stras","year":"2022","unstructured":"Stras WA, Wasiak D, Lagiewska B, et al. Recurrence of hepatocellular carcinoma after liver transplantation: risk factors and predictive models. Ann Transplant. 2022;27: e934924.","journal-title":"Ann Transplant"},{"issue":"Suppl 2","key":"1839_CR9","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1002\/lt.22336","volume":"17","author":"G Germani","year":"2011","unstructured":"Germani G, Gurusamy K, Garcovich M, et al. Which matters most: number of tumors, size of the largest tumor, or total tumor volume? Liver Transpl. 2011;17(Suppl 2):S58-66.","journal-title":"Liver Transpl"},{"issue":"4","key":"1839_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jamcollsurg.2006.06.016","volume":"203","author":"A Bharat","year":"2006","unstructured":"Bharat A, Brown DB, Crippin JS, et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg. 2006;203(4):411\u201320.","journal-title":"J Am Coll Surg"},{"issue":"3","key":"1839_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jvir.2011.11.029","volume":"23","author":"DB Brown","year":"2012","unstructured":"Brown DB, Nikolic B, Covey AM, et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol. 2012;23(3):287\u201394.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"1839_CR12","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","volume":"13","author":"P-A Clavien","year":"2012","unstructured":"Clavien P-A, Lesurtel M, Bossuyt PMM, et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012;13(1):e11\u201322.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1839_CR13","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/j.transproceed.2012.07.004","volume":"44","author":"G Felga","year":"2012","unstructured":"Felga G, Evangelista AS, Salvalaggio PR, et al. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria. Transplant Proc. 2012;44(8):2459\u201361.","journal-title":"Transplant Proc"},{"issue":"7","key":"1839_CR14","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.transproceed.2006.06.030","volume":"38","author":"JW Park","year":"2006","unstructured":"Park JW, Lee KW, Kim SJ, et al. Outcome of patients with recurrent hepatocellular carcinoma in liver transplantation. Transplant Proc. 2006;38(7):2121\u20132.","journal-title":"Transplant Proc"},{"issue":"1","key":"1839_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1200\/JCO.1999.17.1.324","volume":"17","author":"HJ Schlitt","year":"1999","unstructured":"Schlitt HJ, Neipp M, Weimann A, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol. 1999;17(1):324\u201331.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1839_CR16","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1177\/2050640619840221","volume":"7","author":"F Foerster","year":"2019","unstructured":"Foerster F, Hoppe-Lotichius M, Vollmar J, et al. Long-term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation centre. United Eur Gastroenterol J. 2019;7(6):838\u201349.","journal-title":"United Eur Gastroenterol J"},{"issue":"4","key":"1839_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrgastro.2016.193","volume":"14","author":"G Sapisochin","year":"2017","unstructured":"Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 2017;14(4):203\u201317.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"1839_CR18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/ajt.14549","volume":"18","author":"N Mehta","year":"2018","unstructured":"Mehta N, Dodge JL, Roberts JP, et al. Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database. Am J Transplant. 2018;18(5):1206\u201313.","journal-title":"Am J Transplant"},{"issue":"4","key":"1839_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.12.025","volume":"220","author":"VG Agopian","year":"2015","unstructured":"Agopian VG, Harlander-Locke M, Zarrinpar A, et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg. 2015;220(4):416\u201327.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"1839_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/lt.23652","volume":"19","author":"K Berry","year":"2013","unstructured":"Berry K, Ioannou GN. Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma. Liver Transpl. 2013;19(6):634\u201345.","journal-title":"Liver Transpl"},{"issue":"Suppl 2","key":"1839_CR21","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/lt.22368","volume":"17","author":"AS Gouw","year":"2011","unstructured":"Gouw AS, Balabaud C, Kusano H, et al. Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl. 2011;17(Suppl 2):S72-80.","journal-title":"Liver Transpl"},{"key":"1839_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.781820","volume":"12","author":"J-C Yang","year":"2022","unstructured":"Yang J-C, Hu J-J, Li Y-X, et al. Clinical applications of liquid biopsy in hepatocellular carcinoma. Front Oncol. 2022;12: 781820.","journal-title":"Front Oncol"},{"issue":"8","key":"1839_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/hepr.12196","volume":"44","author":"F Hirokawa","year":"2014","unstructured":"Hirokawa F, Hayashi M, Miyamoto Y, et al. Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma. Hepatol Res. 2014;44(8):846\u201353.","journal-title":"Hepatol Res"},{"issue":"3","key":"1839_CR24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.gastro.2009.06.003","volume":"137","author":"S Roayaie","year":"2009","unstructured":"Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137(3):850\u20135.","journal-title":"Gastroenterology"},{"issue":"1","key":"1839_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1245\/s10434-012-2513-1","volume":"20","author":"M Rodriguez-Peralvarez","year":"2013","unstructured":"Rodriguez-Peralvarez M, Luong TV, Andreana L, et al. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;20(1):325\u201339.","journal-title":"Ann Surg Oncol"},{"key":"1839_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.21037\/tgh.2017.08.02","volume":"2","author":"RS Pinheiro","year":"2017","unstructured":"Pinheiro RS, Waisberg DR, Nacif LS, et al. Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure? Transl Gastroenterol Hepatol. 2017;2:68.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"1","key":"1839_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001086","volume":"7","author":"A Aggarwal","year":"2021","unstructured":"Aggarwal A, Te HS, Verna EC, et al. A national survey of hepatocellular carcinoma surveillance practices following liver transplantation. Transplant Direct. 2021;7(1): e638.","journal-title":"Transplant Direct"},{"issue":"6","key":"1839_CR28","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/TP.0000000000003196","volume":"104","author":"M Berenguer","year":"2020","unstructured":"Berenguer M, Burra P, Ghobrial M, et al. Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma. Working group report from the ILTS transplant oncology consensus conference. Transplantation. 2020;104(6):1143\u20139.","journal-title":"Transplantation"},{"issue":"10","key":"1839_CR29","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1097\/TP.0000000000003117","volume":"104","author":"DD Lee","year":"2020","unstructured":"Lee DD, Sapisochin G, Mehta N, et al. Surveillance for HCC after liver transplantation: increased monitoring may yield aggressive treatment options and improved postrecurrence survival. Transplantation. 2020;104(10):2105\u201312.","journal-title":"Transplantation"},{"issue":"4","key":"1839_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1046\/j.0007-1323.2001.02054.x","volume":"89","author":"S Kubo","year":"2002","unstructured":"Kubo S, Nishiguchi S, Hirohashi K, et al. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg. 2002;89(4):418\u201322.","journal-title":"Br J Surg"},{"issue":"10","key":"1839_CR31","doi-asserted-by":"publisher","first-page":"963","DOI":"10.7326\/0003-4819-134-10-200105150-00010","volume":"134","author":"S Kubo","year":"2001","unstructured":"Kubo S, Nishiguchi S, Hirohashi K, et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med. 2001;134(10):963\u20137.","journal-title":"Ann Intern Med"},{"key":"1839_CR32","unstructured":"NCCN (2019) NCCN clinical practice guidelines in oncology (NCCN guidelines). https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx. Hepatobiliary Cancers. (Version 1). Accessed 9 May 2023."},{"issue":"10 HCC","key":"1839_CR33","first-page":"e6031","volume":"12","author":"Y Du","year":"2012","unstructured":"Du Y, Su T, Ding Y, et al. Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation. Hepat Mon. 2012;12(10 HCC):e6031.","journal-title":"Hepat Mon"},{"issue":"3","key":"1839_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5114\/ceh.2018.78127","volume":"4","author":"M Pazgan-Simon","year":"2018","unstructured":"Pazgan-Simon M, Simon KA, Jarowicz E, et al. Hepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrence. Clin Exp Hepatol. 2018;4(3):210\u20136.","journal-title":"Clin Exp Hepatol"},{"issue":"2","key":"1839_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000489021","volume":"8","author":"LC Lu","year":"2019","unstructured":"Lu LC, Lee YH, Chang CJ, et al. Increased expression of programmed death-ligand 1 in infiltrating immune cells in hepatocellular carcinoma tissues after sorafenib treatment. Liver Cancer. 2019;8(2):110\u201320.","journal-title":"Liver Cancer"},{"issue":"20","key":"1839_CR36","doi-asserted-by":"publisher","first-page":"8067","DOI":"10.1158\/0008-5472.CAN-09-0901","volume":"69","author":"K Wu","year":"2009","unstructured":"Wu K, Kryczek I, Chen L, et al. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7\u2013H1\/programmed death-1 interactions. Cancer Res. 2009;69(20):8067\u201375.","journal-title":"Cancer Res"},{"key":"1839_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.21037\/tgh.2017.09.06","volume":"2","author":"J Lerut","year":"2017","unstructured":"Lerut J, Iesari S, Foguenne M, et al. Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression? Transl Gastroenterol Hepatol. 2017;2:80.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"6","key":"1839_CR38","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jhep.2013.07.012","volume":"59","author":"M Rodr\u00edguez-Per\u00e1lvarez","year":"2013","unstructured":"Rodr\u00edguez-Per\u00e1lvarez M, Tsochatzis E, Naveas MC, et al. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma. J Hepatol. 2013;59(6):1193\u20139.","journal-title":"J Hepatol"},{"issue":"7","key":"1839_CR39","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/cancers13071617","volume":"13","author":"RR Ossami Saidy","year":"2021","unstructured":"Ossami Saidy RR, Postel MP, Pfl\u00fcger MJ, et al. Minimization of immunosuppressive therapy is associated with improved survival of liver transplant patients with recurrent hepatocellular carcinoma. Cancers (Basel). 2021;13(7):1617.","journal-title":"Cancers (Basel)"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01839-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-023-01839-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01839-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T16:30:13Z","timestamp":1700757013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-023-01839-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1839"],"URL":"https:\/\/doi.org\/10.1007\/s12328-023-01839-1","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"15 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were performed in accordance with the ethical standards in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"This study does not contain patient identifying information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}